Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06691321

Caspofungin for Pneumocystis Pneumonia in PLWHIV.

Sponsor: Instituto Nacional de Enfermedades Respiratorias

View on ClinicalTrials.gov

Summary

Pneumocystis jirovecii pneumonia is a significant concern in peaple with HIV/AIDS, often severe and potentially fatal. While trimethoprim/sulfamethoxazole remains the primary treatment, safety concerns exist with alternative options. Research on Pneumocystis jirovecii's beta-D glucan composition has prompted investigations into echinocandins like caspofungin, showing promise in murine models and some positive results in human studies. Evaluating caspofungin's efficacy through observational studies is crucial due to safety advantages over current treatments and limited documented data.

Official title: Efficacy of Caspofungin for Pneumocystis Jirovecii Pneumonia in People Living With HIV/AIDS.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2023-08-01

Completion Date

2025-09-01

Last Updated

2024-11-19

Healthy Volunteers

No

Locations (1)

Center for Research in Infectious Diseases (CIENI)

Mexico City, Tlalpan, Mexico